Ann: Bluechiip adds third top-20 global pharma to customer list, page-16

People have confidence. some years ago Medpace researched all tracking products on the market and concluded bluechiip was the best and may be the future. Top 20 global pharma companies are not going to invest in a company that can't supply product. You can be sure they have done their due diligence before committing to changing their temperature and tracking operations. IMO the directors are pulling out all stops to maintain cash flow before a significant signing-FUJI. Some big investors recently sold out - hence share price down. More staff employed, more companies jumping on board, directors buying shares. Gotta keep the faith